Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesFeb 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 8, 2017View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJan 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 13, 2016View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 13, 2016View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 25, 2016View HTMLDownload DOCDownload PDF
1-25      26-50      51-63
Top News
Nov 16, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Dr. Mark A. Sirgo, Vice...

Nov 9, 2017

BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, and provided an update on recent business highlights and...

Oct 30, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on...

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com